Chiome Bioscience Inc.
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
4583 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 渋谷区本町三丁目１２番１号
- Website:
- https://www.chiome.co.jp/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Chiome Bioscience Inc. is a clinical-stage biotechnology company established in 2005, specializing in the research and development of therapeutic antibodies. The company focuses on addressing unmet medical needs by creating innovative antibody-based drugs. It utilizes a portfolio of proprietary technologies, most notably its ADLib® system, to accelerate the discovery and selection of optimal antibody candidates for its drug pipeline. Chiome Bioscience is engaged in advancing its own therapeutic programs and providing antibody development support and services to partners in the pharmaceutical industry.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Chiome Bioscience Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-12 09:05 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2025-08-12 09:04 |
Interim Report
半期報告書－第22期(2025/01/01－2025/12/31)
|
Japanese | 188.7 KB | |
| 2025-03-28 08:09 |
Regulatory News Service
内部統制報告書－第21期(2024/01/01－2024/12/31)
|
Japanese | 22.8 KB | |
| 2025-03-28 08:07 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2025-03-28 08:05 |
Annual Report
有価証券報告書－第21期(2024/01/01－2024/12/31)
|
Japanese | 1.6 MB | |
| 2025-03-28 08:03 |
Regulatory News Service
臨時報告書
|
Japanese | 30.6 KB | |
| 2025-02-19 08:04 |
Regulatory News Service
臨時報告書
|
Japanese | 19.7 KB | |
| 2024-11-15 07:48 |
Regulatory News Service
確認書
|
Japanese | 8.4 KB | |
| 2024-11-15 07:45 |
Regulatory News Service
訂正有価証券報告書－第20期(2023/01/01－2023/12/31)
|
Japanese | 767.5 KB | |
| 2024-08-13 09:10 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2024-08-13 09:08 |
Interim Report
半期報告書－第21期(2024/01/01－2024/12/31)
|
Japanese | 226.8 KB | |
| 2024-07-05 08:02 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 264.6 KB | |
| 2024-05-14 09:12 |
Quarterly Report
四半期報告書－第21期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 185.2 KB | |
| 2024-05-14 09:12 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2024-03-26 08:50 |
Regulatory News Service
臨時報告書
|
Japanese | 23.1 KB |
Automate Your Workflow. Get a real-time feed of all Chiome Bioscience Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Chiome Bioscience Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
